// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Low‐molecular‐Weight Heparin Use in Neonates: A Systematic Review

J. Ting - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Heparin

Development of an Umbilical Cord and Pediatric Plasma Bank

L. Calvert - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pediatric May‐Thurner Syndrome ‐ A Systematic Review

N. Cullinan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Deep vein thrombosis

N/A

Insights into Defects in Ca2+‐Mobilization in Platelets from Patients with von Willebrand Disease Type 2B (VWD2B)

M. Rand - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Twin-reversed arterial perfusion

annexin A5

The Cell‐cycle Control Pathway Gwl/MASTL‐ENSA/ARPP19‐PP2A Is Present and Active in Human Platelets

E. Kumm - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Coenzyme Q10 Attenuates Platelet Function through Targeting cAMP/PKA Pathway

Y. Yang - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Coenzyme Q10

Potential for Ice Recrystallisation Inhibitors to Improve Cryopreserved Platelet Recovery and Quality

L. Waters - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

DMSO

Platelets Express a Truncated Form of TrkB Involved in BDNF Signaling

I. Boukhatem - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

Clinical Predictiveness of Six Major Platelet Function Tests Used to Assess Aspirin Response in Patients with Stable Coronary Artery Disease ‐ 10‐year Follow‐up

M. Lordkipanidz - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Stable coronary artery disease

Adenosine

Reversing Oral Antiplatelet Agents with Platelet Transfusion: A Review

P. Kruger - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Reversal of the Anti‐aggregant Effect of Ticagrelor Using Untreated Platelets

P. Kruger - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ticagrelor

Detection and Treatment of Helicobacter pylori in Patients with Immune Thrombocytopenia: An International Survey

P. Vishnu - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Immune thrombocytopenia

N/A

Efficacy of Thrombopoietin Receptor Agonists in Pediatric Immune Thrombocytopenia: Systematic Review

S. Abegunde - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Immune thrombocytopenia

N/A

Assessment of Platelet Aggregation in Umbilical Cord Blood Using Multiple Electrode Aggregometry

S.J. Israels - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Twin-reversed arterial perfusion

N/A

The Role of the Androgen Receptor in Prostate Cancer‐induced Platelet Aggregation and Invasion

J. Rudzinski - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Bicalutamide

Preferential Aggregation of Platelets by Prostate Cancer Cells with Stem Cell Markers

J. Rudzinski - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Prostacyclin

Accuracy of the Ottawa Score in Risk Stratification of Recurrent Venous Thromboembolism in Patients with Cancer‐associated Venous Thromboembolism. A Systematic Review and Meta‐analysis

A. Delluc - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

The Ottawa Score Does Not Predict Recurrent Venous Thromboembolism in Cancer Patients: Results from the Hokusai‐VTE Cancer Study

F.T.M. Bosch - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

dalteparin Subcutaneous

Incidence, Risk Factors and Clinical Outcomes of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the BACAP Cohort

C. Frere - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Bleeding in the Prevention of Cancer‐associated Venous Thromboembolism: Secondary Analysis of the AVERT Study

L.A. Castellucci - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved